Publications
Targeting drug-resistant cancers: in silico repurposing of the cholesterol-lowering drug Ezetimibe for selective inhibition of aldo-keto reductase 1B10 (AKR1B10)
Turning down PI3K/AKT/mTOR signalling pathway by natural products: an in silico multi-target approach